Answers are grounded in this paper and cite their sources.
Effective dose (E) was created to provide a dose quantity linked to health detriment due to stochastic effects, because the radiation dose quantities that can be measured only bear a limited relationship to health risk(1,2). The International Commission on Radiological Protection (ICRP) made clear that it was intended for use in the assessment of risks in general terms for radiation protection purposes. However, E was also a convenient dose quantity through which an indication of the level of risk from medical exposures could be obtained for use in clinical justification. It is now applied extensively in assessing doses from medical exposures and has been determined in 60% of the studies reported in Radiation Protection Dosimetry in the last 3 y. Unfortunately, some of those using E attribute to it a precision that is not warranted. This has fuelled debate about whether E is an appropriate dose quantity to apply to medical exposures (D. Brenner and W. Huda, in preparation). E can play a valuable role provided its application is not extended further than is justified by the supporting evidence. It is the single dose quantity that has a relationship to health risks from stochastic effects and so can be used in the justification of medical exposures. Moreover, E is a useful relative dose indicator during optimisation of radiological procedures, particularly for determining the impact of changes in X-ray beam quality, as it takes account of doses to deeper tissues, which are not included in entrance surface dose (ESD) or dose-area product (DAP). In order to promote this approach, this editorial examines the uncertainties in E and proposes criteria that could be applied to its use for medical exposures.
No takes yet. Share an insight, caveat, or question.
C J Martin (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: